🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be a two-part with an open-label, single oral dose, two-way...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-02-11
Trial ID
NCT02371603
Epidemiologic, social and economic burdens of type 2 diabetes mellitus (T2D...
Status
Completed
Location
Azienda Ospedaliero Universitaria di Parma
Start Date
2020-09-01
Trial ID
NCT04271189
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of aloglip...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00328627
Treatments Being Tested
The goal of this clinical research study is to learn how Actos (pioglitazon...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2010-02
Trial ID
NCT00951379
Treatments Being Tested
The purpose of this clinical research study is to learn if BMS-512148 (Dapa...
Status
Completed
Location
Local Institution
Start Date
2010-06
Trial ID
NCT01095666
Treatments Being Tested
Type 2 diabetes is an epidemic. Its long-term consequences translate into e...
Status
Completed
Location
Department of Geriatrics and Metabolic Diseases
Start Date
2007-10
Trial ID
NCT00815399
Treatments Being Tested
This exploratory study will assess the efficacy of combined pioglitazone an...
Status
Recruiting
Location
Seoul National University Bundang Hospital
Start Date
2025-01-01
Trial ID
NCT06989723
This is an open-label, cross-over, fixed-sequence study. All subjects will ...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02473627
Treatments Being Tested
The primary objective is to test the hypothesis that adjunctive pioglitazon...
Status
Terminated
Location
University Hospitals Cleveland Medical Center - Mood Disorders Program
Start Date
2012-09
Trial ID
NCT01717040
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of sitagli...
Status
Completed
Location
Multiple Locations
Start Date
2008-01-15
Trial ID
NCT00541450